Showing 6781-6790 of 19337 results for "".
Gene Variations Guide Anticoagulation Strategies After Cardiac Catheterization
https://reachmd.com/programs/primary-care-today/gene-variations-guide-anticoagulation-strategies-after-cardiac-catheterization/7978/Advances in genetic testing to detect variances in response to anticoagulation therapies are improving primary care personalization for patients.Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT
https://reachmd.com/programs/cme/surgical-crossroads-practical-considerations-for-optimizing-treatment-in-tgct/48907/Explore TGCT recognition, clinical evidence, treatment strategies, and management of adverse events with CSF1R inhibitors in an interdisciplinary context.DECAF Trial: Does Eliminating Coffee Reduce Atrial Fibrillation Recurrence in Symptomatic Patients?
https://reachmd.com/clinical-practice/cardiology/decaf-trial-does-eliminating-coffee-reduce-atrial-fibrillation-recurrence-in-symptomatic-patients/48690/Does caffeine abstinence affect atrial fibrillation recurrence in patients with symptomatic AF? Tune in for a review of the DECAF trial results!The Ambulatory HFrEF Blind Spot: Proactively Reducing CV Mortality Risk Despite Optimized GDMT
https://reachmd.com/programs/cme/the-ambulatory-hfref-blind-spot-proactively-reducing-cv-mortality-risk-despite-optimized-gdmt/48810/Drs. Bauersachs, Butler & Lam discuss persistent residual risk in HFrEF, the use of sGC stimulators to reduce risk, and supporting evidence for this approach.Beyond the Primary Endpoint: What OCEANIC-STROKE Subtype Analyses Reveal About Asundexian’s Potential
https://reachmd.com/programs/global-neurology-academy/beyond-the-primary-endpoint-what-oceanic-stroke-subtype-analyses-reveal-about-asundexians-potential/54416/Dive into stroke subtype data from OCEANIC-STROKE to see how asundexian's effects vary across clinically distinct patient populations.Unlocking the CSF1R Code: Targeted Pathways and Tailored Choices
https://reachmd.com/programs/cme/unlocking-the-csf1r-code-targeted-pathways-and-tailored-choices/48905/Explore TGCT recognition, clinical evidence, treatment strategies, and management of adverse events with CSF1R inhibitors in an interdisciplinary context.Hepatic Encephalopathy: More Common Than You Think
https://reachmd.com/programs/cme/Hepatic-Encephalopathy-More-Common-Than-You-Think/39786/Explore diagnostic and treatment challenges in patients with hepatic encephalopathy to improve outcomes for your patients.Strategies for Stronger Skin: Tissue Regeneration & Wound Healing
https://reachmd.com/programs/dermconsult/strategies-for-stronger-skin-tissue-regeneration-and-wound-healing/12385/Can our skin’s natural immune response be leveraged to improve tissue regeneration in wound healing?Exploring the Prevalence of Congenital Heart Disease in Conjoined Twins
https://reachmd.com/programs/heart-matters/exploring-the-prevalence-of-congenital-heart-disease-in-conjoined-twins/12216/With limited information available on congenital heart disease, how can we better treat our patients with this genetic condition?Physician & Patient Relationships: A Key Component of Diagnosing GI Disorders
https://reachmd.com/programs/gi-insights/physician-and-patient-relationships-a-key-component-of-diagnosing-gi-disorders/12168/When diagnosing GI disorders, what do we need to know about the importance of the doctor-patient relationship?